A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding

Author(s):  Miller David G

Issue:  Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue

Abstract:  

Related Keywords: David G. Miller, RPh, International Academy of Compounding Pharmacists, draft memorandum of understanding addressing certain distributions of compounded human drug products between the states and the U.S. Food and Drug Administration, IACP, U.S. Food and Drug Administration, FDA, nonsterile office-use compounded medications, access to care, regulations

Related Categories: BUSINESS, LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding	Miller David G	Sep/Oct 2015	375	Buy
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter	Miller David G	May/Jun 2014	208	Buy
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed	Brunner Scott	Jul/Aug 2020	296-297	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance	Miller David G	Nov/Dec 2015	449-450	Buy
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013	Miller David G	Jan/Feb 2014	35-36	Buy
Standing Together Fixing the Drug Quality and Security Act	Miller David G	Mar/Apr 2015	104-106	Buy